Anhui Anke Biotechnology (Group) Co., Ltd.
SHZ: 300009.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jian Ping Yao
- Employees
- 2,647
- Headquarters
- Hefei, China
- IPO year
- 2009
- Market cap
- CN¥14.8B
- Website
- https://www.ankebio.com
Loading 300009…
Loading profile data…Frequently asked questions about 300009
What does Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) do?
Anhui Anke Biotechnology (Group) Co., Ltd. develops, produces, and markets pharmaceutical products in China and internationally. The company offers recombinant human growth hormone for injection under the Ansomone name; and recombinant human interferon alpha 2b lyophilized powder, liquid, and prefilled syringe for injection, as well as recombina...
Where does 300009.SZ trade?
Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300009.SZ in?
Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Anhui Anke Biotechnology (Group) Co., Ltd.?
Jian Ping Yao is the chief executive officer of Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ).
Where is Anhui Anke Biotechnology (Group) Co., Ltd. headquartered?
Anhui Anke Biotechnology (Group) Co., Ltd. is headquartered in China.
Does 300009.SZ pay a dividend?
Yes — Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) paid a trailing twelve-month dividend of CNY 0.15 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300009.SZ go public?
Anhui Anke Biotechnology (Group) Co., Ltd. (300009.SZ) completed its initial public offering in 2009.